What Is Genomics? Core Concepts, Technologies, and Applications
Genomics is the large-scale study of an organism's complete set of genetic material—its genome—including how genes are structured, expressed, regulated, and how they vary across individuals and populations. It differs from classical genetics, which typically studies one or a few genes at a time, and from proteomics, which studies the full complement of proteins. Genomics matters most when you need a system-level view: identifying disease-associated variants, mapping expression across tissues, or connecting genotype to clinical outcome. The sections below cover the core concepts, the main subfields and technologies, and how genomics links to proteomics and precision medicine.
Genomics vs. genetics vs. proteomics
These three fields answer different questions and often work together:
| Field | Unit of study | Typical question | Example output |
|---|---|---|---|
| Genetics | One or a few genes | Does this variant cause this trait? | A confirmed causal variant |
| Genomics | The whole genome | What variants exist across the genome, and what do they do? | Variant catalog, expression map |
| Proteomics | The full protein set | Which proteins are present, modified, or changing? | Protein abundance and modification profiles |
Genomics and proteomics are complementary: DNA sequence tells you what could be expressed, while proteomics tells you what is actually present and modified in a sample. Multi-omics combines these layers—genomics, transcriptomics, proteomics, metabolomics—to build a more complete picture than any single layer provides.
Main subfields of genomics
- Functional genomics: how genes and regulatory elements drive biological function, often via CRISPR screens and gene engineering.
- Single-cell genomics: resolves cell-to-cell differences that bulk sequencing averages out.
- Spatial transcriptomics: measures gene expression while preserving where in a tissue it occurs.
- Comparative and population genomics: variation across species or across large groups of individuals.
Core sequencing and analysis technologies
Sequencing platforms differ mainly in read length, throughput, and what they resolve:
- Short-read sequencing: high accuracy and throughput; strong for variant calling and counting, weaker for repetitive or structurally complex regions.
- Long-read sequencing: spans repeats and structural variants that short reads miss.
- Single-cell and spatial platforms: add resolution in cell identity and tissue location.
- Computational biology / bioinformatics: turns raw reads into variants, expression values, and interpretable results—an inseparable part of any genomics pipeline.
The McDonnell Genome Institute (MGI) at WashU describes offering these capabilities through dedicated technology hubs, including a Genome Technology Access Center (short-read, long-read, high-throughput proteomics, single-cell genomics, spatial transcriptomics, bioinformatics), a Genome Engineering & Stem Cell Center (genome-edited cell lines and model organisms, patient-derived iPSCs, CRISPR screening), a Mass Spectrometry Technology Access Center (proteomics, metabolomics, lipidomics, PTM analysis, native mass spectrometry, spatial multi-omics), and a Functional Imaging group (genetic cellular screening, drug screening, live-cell isolation, image analysis).
How genomics feeds proteomics, multi-omics, and precision medicine
The flow is roughly: genome → transcriptome → proteome → phenotype. Genomics identifies candidate variants; functional and single-cell methods test what those variants do; proteomics and mass spectrometry confirm whether the effect appears at the protein level; multi-omics integrates the layers. In precision medicine, this chain supports biomarker discovery and variant interpretation—for example, using functional imaging and cellular screening to work out whether a specific variant is likely to matter clinically.
Applications and where to start
Common real-world uses include biomarker discovery, clinical research, drug screening, and variant elucidation. MGI reports 16 years of average employee tenure, a 95% repeat partner rate, 65 current academic institute partners, and 56 current biopharma partners—useful signals if you are evaluating a genomics collaborator for a difficult or large-scale project.
If you are scoping a project, match the method to the question: short-read sequencing for variant discovery at scale, long-read for structural complexity, single-cell or spatial methods for heterogeneity and location, and mass spectrometry when the protein layer is the decision point. MGI's site provides a "Start a Project" entry point and per-hub "Learn More" pages for each technology area.